Historical Valuation
Parker-Hannifin Corp (PH) is now in the Overvalued zone, suggesting that its current forward PE ratio of 28.98 is considered Overvalued compared with the five-year average of 18.95. The fair price of Parker-Hannifin Corp (PH) is between 712.96 to 915.78 according to relative valuation methord. Compared to the current price of 923.58 USD , Parker-Hannifin Corp is Overvalued By 0.85%.
Relative Value
Fair Zone
712.96-915.78
Current Price：923.58
0.85%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Parker-Hannifin Corp (PH) has a current Price-to-Book (P/B) ratio of 8.19. Compared to its 3-year average P/B ratio of 5.89 , the current P/B ratio is approximately 39.13% higher. Relative to its 5-year average P/B ratio of 5.33, the current P/B ratio is about 53.48% higher. Parker-Hannifin Corp (PH) has a Forward Free Cash Flow (FCF) yield of approximately 3.00%. Compared to its 3-year average FCF yield of 4.31%, the current FCF yield is approximately -30.45% lower. Relative to its 5-year average FCF yield of 4.96% , the current FCF yield is about -39.54% lower.
P/B
Median3y
5.89
Median5y
5.33
FCF Yield
Median3y
4.31
Median5y
4.96
Competitors Valuation Multiple
AI Analysis for PH
The average P/S ratio for PH competitors is 3.46, providing a benchmark for relative valuation. Parker-Hannifin Corp Corp (PH.N) exhibits a P/S ratio of 5.27, which is 52.56% above the industry average. Given its robust revenue growth of 3.67%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PH
1Y
3Y
5Y
Market capitalization of PH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PH currently overvalued or undervalued?
Parker-Hannifin Corp (PH) is now in the Overvalued zone, suggesting that its current forward PE ratio of 28.98 is considered Overvalued compared with the five-year average of 18.95. The fair price of Parker-Hannifin Corp (PH) is between 712.96 to 915.78 according to relative valuation methord. Compared to the current price of 923.58 USD , Parker-Hannifin Corp is Overvalued By 0.85% .
What is Parker-Hannifin Corp (PH) fair value?
PH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Parker-Hannifin Corp (PH) is between 712.96 to 915.78 according to relative valuation methord.
How does PH's valuation metrics compare to the industry average?
The average P/S ratio for PH's competitors is 3.46, providing a benchmark for relative valuation. Parker-Hannifin Corp Corp (PH) exhibits a P/S ratio of 5.27, which is 52.56% above the industry average. Given its robust revenue growth of 3.67%, this premium appears unsustainable.
What is the current P/B ratio for Parker-Hannifin Corp (PH) as of Jan 10 2026?
As of Jan 10 2026, Parker-Hannifin Corp (PH) has a P/B ratio of 8.19. This indicates that the market values PH at 8.19 times its book value.
What is the current FCF Yield for Parker-Hannifin Corp (PH) as of Jan 10 2026?
As of Jan 10 2026, Parker-Hannifin Corp (PH) has a FCF Yield of 3.00%. This means that for every dollar of Parker-Hannifin Corp’s market capitalization, the company generates 3.00 cents in free cash flow.
What is the current Forward P/E ratio for Parker-Hannifin Corp (PH) as of Jan 10 2026?
As of Jan 10 2026, Parker-Hannifin Corp (PH) has a Forward P/E ratio of 28.98. This means the market is willing to pay $28.98 for every dollar of Parker-Hannifin Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Parker-Hannifin Corp (PH) as of Jan 10 2026?
As of Jan 10 2026, Parker-Hannifin Corp (PH) has a Forward P/S ratio of 5.27. This means the market is valuing PH at $5.27 for every dollar of expected revenue over the next 12 months.